Sales 2024 * | 48.13B 45.25B | Sales 2025 * | 49.85B 46.86B | Capitalization | 203B 191B |
---|---|---|---|---|---|
Net income 2024 * | 10.65B 10.01B | Net income 2025 * | 11.58B 10.89B | EV / Sales 2024 * | 4.47 x |
Net Debt 2024 * | 11.86B 11.15B | Net Debt 2025 * | 10.17B 9.56B | EV / Sales 2025 * | 4.28 x |
P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
16.2
x | Employees | 76,057 |
Yield 2024 * |
3.93% | Yield 2025 * |
4.06% | Free-Float | 81.95% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-10.02% | 194B | |
-11.81% | 144B | |
-8.80% | 141B |